240 related articles for article (PubMed ID: 27357679)
1. Sleeping Beauty screen reveals Pparg activation in metastatic prostate cancer.
Ahmad I; Mui E; Galbraith L; Patel R; Tan EH; Salji M; Rust AG; Repiscak P; Hedley A; Markert E; Loveridge C; van der Weyden L; Edwards J; Sansom OJ; Adams DJ; Leung HY
Proc Natl Acad Sci U S A; 2016 Jul; 113(29):8290-5. PubMed ID: 27357679
[TBL] [Abstract][Full Text] [Related]
2. Genetic ablation of FASN attenuates the invasive potential of prostate cancer driven by Pten loss.
Bastos DC; Ribeiro CF; Ahearn T; Nascimento J; Pakula H; Clohessy J; Mucci L; Roberts T; Zanata SM; Zadra G; Loda M
J Pathol; 2021 Mar; 253(3):292-303. PubMed ID: 33166087
[TBL] [Abstract][Full Text] [Related]
3. PTEN ameliorates high glucose-induced lipid deposits through regulating SREBP-1/FASN/ACC pathway in renal proximal tubular cells.
Hao J; Zhu L; Zhao S; Liu S; Liu Q; Duan H
Exp Cell Res; 2011 Jul; 317(11):1629-39. PubMed ID: 21320485
[TBL] [Abstract][Full Text] [Related]
4. P300 acetyltransferase regulates fatty acid synthase expression, lipid metabolism and prostate cancer growth.
Gang X; Yang Y; Zhong J; Jiang K; Pan Y; Karnes RJ; Zhang J; Xu W; Wang G; Huang H
Oncotarget; 2016 Mar; 7(12):15135-49. PubMed ID: 26934656
[TBL] [Abstract][Full Text] [Related]
5. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis.
Fang J; Ding M; Yang L; Liu LZ; Jiang BH
Cell Signal; 2007 Dec; 19(12):2487-97. PubMed ID: 17826033
[TBL] [Abstract][Full Text] [Related]
6. Posttranslational regulation of membrane type 1-matrix metalloproteinase (MT1-MMP) in mouse PTEN null prostate cancer cells: Enhanced surface expression and differential O-glycosylation of MT1-MMP.
Kim S; Huang W; Mottillo EP; Sohail A; Ham YA; Conley-Lacomb MK; Kim CJ; Tzivion G; Kim HR; Wang S; Chen YQ; Fridman R
Biochim Biophys Acta; 2010 Nov; 1803(11):1287-97. PubMed ID: 20620173
[TBL] [Abstract][Full Text] [Related]
7. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis.
Tan M; Xu J; Siddiqui J; Feng F; Sun Y
Mol Cancer; 2016 Dec; 15(1):81. PubMed ID: 27955654
[TBL] [Abstract][Full Text] [Related]
8. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.
Bouali S; Chrétien AS; Ramacci C; Rouyer M; Becuwe P; Merlin JL
Oncol Rep; 2009 Mar; 21(3):731-5. PubMed ID: 19212633
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans.
Che L; Chi W; Qiao Y; Zhang J; Song X; Liu Y; Li L; Jia J; Pilo MG; Wang J; Cigliano A; Ma Z; Kuang W; Tang Z; Zhang Z; Shui G; Ribback S; Dombrowski F; Evert M; Pascale RM; Cossu C; Pes GM; Osborne TF; Calvisi DF; Chen X; Chen L
Gut; 2020 Jan; 69(1):177-186. PubMed ID: 30954949
[TBL] [Abstract][Full Text] [Related]
10. Prolonged high-glucose exposure decreased SREBP-1/FASN/ACC in Schwann cells of diabetic mice via blocking PI3K/Akt pathway.
Zhu L; Du W; Liu Y; Cheng M; Wang X; Zhang C; Lv X; Li F; Zhao S; Hao J
J Cell Biochem; 2019 Apr; 120(4):5777-5789. PubMed ID: 30362584
[TBL] [Abstract][Full Text] [Related]
11. Loss of PTEN stabilizes the lipid modifying enzyme cytosolic phospholipase A₂α via AKT in prostate cancer cells.
Vignarajan S; Xie C; Yao M; Sun Y; Simanainen U; Sved P; Liu T; Dong Q
Oncotarget; 2014 Aug; 5(15):6289-99. PubMed ID: 25026288
[TBL] [Abstract][Full Text] [Related]
12. AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis.
Li N; Xue W; Yuan H; Dong B; Ding Y; Liu Y; Jiang M; Kan S; Sun T; Ren J; Pan Q; Li X; Zhang P; Hu G; Wang Y; Wang X; Li Q; Qin J
J Clin Invest; 2017 Apr; 127(4):1284-1302. PubMed ID: 28319045
[TBL] [Abstract][Full Text] [Related]
13. PPAR-gamma induced AKT3 expression increases levels of mitochondrial biogenesis driving prostate cancer.
Galbraith LCA; Mui E; Nixon C; Hedley A; Strachan D; MacKay G; Sumpton D; Sansom OJ; Leung HY; Ahmad I
Oncogene; 2021 Apr; 40(13):2355-2366. PubMed ID: 33654198
[TBL] [Abstract][Full Text] [Related]
14. 1,25-dihydroxyvitamin D(3) and PI3K/AKT inhibitors synergistically inhibit growth and induce senescence in prostate cancer cells.
Axanova LS; Chen YQ; McCoy T; Sui G; Cramer SD
Prostate; 2010 Nov; 70(15):1658-71. PubMed ID: 20583132
[TBL] [Abstract][Full Text] [Related]
15. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion.
Shukla S; Maclennan GT; Hartman DJ; Fu P; Resnick MI; Gupta S
Int J Cancer; 2007 Oct; 121(7):1424-32. PubMed ID: 17551921
[TBL] [Abstract][Full Text] [Related]
16. HER2 overcomes PTEN (loss)-induced senescence to cause aggressive prostate cancer.
Ahmad I; Patel R; Singh LB; Nixon C; Seywright M; Barnetson RJ; Brunton VG; Muller WJ; Edwards J; Sansom OJ; Leung HY
Proc Natl Acad Sci U S A; 2011 Sep; 108(39):16392-7. PubMed ID: 21930937
[TBL] [Abstract][Full Text] [Related]
17. Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: Still a potential druggable target?
Braglia L; Zavatti M; Vinceti M; Martelli AM; Marmiroli S
Biochim Biophys Acta Mol Cell Res; 2020 Sep; 1867(9):118731. PubMed ID: 32360668
[TBL] [Abstract][Full Text] [Related]
18. CXCR4 and PTEN are involved in the anti-metastatic regulation of anethole in DU145 prostate cancer cells.
Rhee YH; Chung PS; Kim SH; Ahn JC
Biochem Biophys Res Commun; 2014 May; 447(4):557-62. PubMed ID: 24525130
[TBL] [Abstract][Full Text] [Related]
19. PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling.
Conley-LaComb MK; Saliganan A; Kandagatla P; Chen YQ; Cher ML; Chinni SR
Mol Cancer; 2013 Jul; 12(1):85. PubMed ID: 23902739
[TBL] [Abstract][Full Text] [Related]
20. PdpaMn inhibits fatty acid synthase-mediated glycolysis by down-regulating PI3K/Akt signaling pathway in breast cancer.
Okrah EA; Wang Q; Fu H; Chen Q; Gao J
Anticancer Drugs; 2020 Nov; 31(10):1046-1056. PubMed ID: 32649369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
